Yukitaka Kojima, CFA

Within E12 Ventures, Yuki supports our corporate LP’s and is currently focused on several  technology investment sectors (e.g. fintech, digital health, quantum computing). In his parallel role at Mitsui Global Investments, Yuki serves as the board observer for Pica8 & has been involved in multiple direct investments including Rallybio, BioNova, Ensem Therapeutics).

Fluent in both Japanese and English, he previously gained experience in structuring corporate insurance programs, trading commodity derivatives, and managing private equity fund investments as an investment manager at Mitsui & Co.

Yuki received his Bachelor of Economics degree from The University of Tokyo. He is a  Certified Member Analyst of the Securities Analysts Association of Japan, and holds the Chartered Financial Analyst® designation.

In his free time, he likes to workout or to lose count of time playing boardgames such as Dominion, Catan or Poker.